Antibe Therapeutics Announces Discontinuation of Latin American Letter of Intent
Business Wire (press release) TORONTO–(BUSINESS WIRE)–Antibe Therapeutics Inc. (“Antibe” or the “Corporation”) (TSXV: ATE) announces that discussions with the potential Latin American partner with which it executed an LOI in 2012 have been discontinued due to a recent change … |